NCT04716140 Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery
| NCT ID | NCT04716140 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tom Lootens |
| Condition | Hallux Valgus |
| Study Type | INTERVENTIONAL |
| Enrollment | 99 participants |
| Start Date | 2020-09-15 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 99 participants in total. It began in 2020-09-15 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate the point or nonsense of treating cartilage lesions at the level of the first metatarsophalane joint. To date, no clear guidelines have been found in the literature with regard to the treatment of cartilage lesions at the MTP I joint during corrective surgery for hallux valgus, nor has it been investigated whether this can have an effect on the clinical outcome.
Eligibility Criteria
Inclusion Criteria: * hallux valgus Exclusion Criteria: * younger than 30 years, older than 60 years * extra pathologies other than hallux valgus
Frequently Asked Questions
Who can join the NCT04716140 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 60 Years, studying Hallux Valgus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04716140 currently recruiting?
Yes, NCT04716140 is actively recruiting participants. Visit ClinicalTrials.gov or contact Tom Lootens to inquire about joining.
Where is the NCT04716140 trial being conducted?
This trial is being conducted at Ghent, Belgium.
Who is sponsoring the NCT04716140 clinical trial?
NCT04716140 is sponsored by Tom Lootens. The trial plans to enroll 99 participants.